GB9200210D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9200210D0
GB9200210D0 GB929200210A GB9200210A GB9200210D0 GB 9200210 D0 GB9200210 D0 GB 9200210D0 GB 929200210 A GB929200210 A GB 929200210A GB 9200210 A GB9200210 A GB 9200210A GB 9200210 D0 GB9200210 D0 GB 9200210D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929200210A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Bio Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Bio Technology Ltd filed Critical British Bio Technology Ltd
Priority to GB929200210A priority Critical patent/GB9200210D0/en
Publication of GB9200210D0 publication Critical patent/GB9200210D0/en
Priority to GB9226370A priority patent/GB2263109B/en
Pending legal-status Critical Current

Links

GB929200210A 1992-01-07 1992-01-07 Compounds Pending GB9200210D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB929200210A GB9200210D0 (en) 1992-01-07 1992-01-07 Compounds
GB9226370A GB2263109B (en) 1992-01-07 1992-12-16 Nitrogen heterocycle PAF receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929200210A GB9200210D0 (en) 1992-01-07 1992-01-07 Compounds

Publications (1)

Publication Number Publication Date
GB9200210D0 true GB9200210D0 (en) 1992-02-26

Family

ID=10708190

Family Applications (2)

Application Number Title Priority Date Filing Date
GB929200210A Pending GB9200210D0 (en) 1992-01-07 1992-01-07 Compounds
GB9226370A Expired - Fee Related GB2263109B (en) 1992-01-07 1992-12-16 Nitrogen heterocycle PAF receptor antagonists

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9226370A Expired - Fee Related GB2263109B (en) 1992-01-07 1992-12-16 Nitrogen heterocycle PAF receptor antagonists

Country Status (1)

Country Link
GB (2) GB9200210D0 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2140034A1 (en) 1992-07-13 1994-01-20 Xiong Cai 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US6201016B1 (en) 1994-06-27 2001-03-13 Cytomed Incorporated Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
DE19605766A1 (en) * 1996-02-16 1997-08-21 Basf Ag Substituted 2-phenylpyridines
US6747027B1 (en) 1996-07-22 2004-06-08 Pharmacia Corporation Thiol sulfonamide metalloprotease inhibitors
WO1998003164A1 (en) * 1996-07-22 1998-01-29 Monsanto Company Thiol sulfone metalloprotease inhibitors
DE19719621A1 (en) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarboxylic acids
US6800646B1 (en) 1999-02-08 2004-10-05 Pharmacia Corporation Sulfamato hydroxamic acid metalloprotease inhibitor
CA2774959C (en) 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
US6645990B2 (en) 2000-08-15 2003-11-11 Amgen Inc. Thiazolyl urea compounds and methods of uses
US7119203B2 (en) 2002-04-25 2006-10-10 Pharmacia Corporation Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
CA2500652A1 (en) 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
JP2007500747A (en) 2003-05-15 2007-01-18 ディーエムアイ バイオサイエンシズ インコーポレイテッド Treatment of T cell mediated diseases
AP2007004161A0 (en) 2005-04-28 2007-10-31 Pfizer Ltd Amino acid derivatives
JP5544458B2 (en) 2005-07-12 2014-07-09 アンピオ ファーマシューティカルズ，インコーポレイテッド Method of using trilostane III in the manufacture of a pharmaceutical product for treating disease and pharmaceutical product comprising trirostan III
JP5856843B2 (en) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド Pharmaceutical composition using diketopiperazine
SG2014008171A (en) 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
MX355446B (en) 2011-10-28 2018-04-18 Ampio Pharmaceuticals Inc Treatment of rhinitis.
US9351979B2 (en) 2012-12-19 2016-05-31 Ampio Pharmaceuticals, Inc. Methods of treatment of diseases
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
KR20170045274A (en) 2014-08-18 2017-04-26 앰피오 파마슈티컬스 인코퍼레이티드 Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610848A1 (en) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg NEW 1,4-DIAZEPINE
CN1030415A (en) * 1987-02-20 1989-01-18 山之内制药株式会社 Saturated heterocycle carboxamide derivatives and its preparation method
US4992455A (en) * 1987-05-22 1991-02-12 Sumitomo Pharmaceuticals Company, Limited Thiazolidin-4-one derivatives useful for treating diseases caused by platelet activating factor

Also Published As

Publication number Publication date
GB9226370D0 (en) 1993-02-10
GB2263109A (en) 1993-07-14
GB2263109B (en) 1996-05-01

Similar Documents

Publication Publication Date Title
AP9300508A0 (en) Compounds
GB9209628D0 (en) Compounds
GB9200245D0 (en) Compounds
GB9201755D0 (en) Compounds
GB9200210D0 (en) Compounds
GB9201694D0 (en) Compounds
GB9201693D0 (en) Compounds
GB9200209D0 (en) Compounds
GB9210632D0 (en) Compounds
GB9200566D0 (en) Compounds
GB9201751D0 (en) Compounds
GB9202792D0 (en) Compounds
GB9201692D0 (en) Compounds
GB9205741D0 (en) Compounds
GB9207051D0 (en) Compounds
GB9203176D0 (en) Compounds
GB9205737D0 (en) Compounds
GB9205740D0 (en) Compounds
GB9203175D0 (en) Compounds
GB9203174D0 (en) Compounds
GB9203173D0 (en) Compounds
GB9203172D0 (en) Compounds
GB9203171D0 (en) Compounds
GB9202991D0 (en) Compounds
GB9207966D0 (en) Compounds